Ahead of World Tuberculosis Day on 24 March, the WHO has said that global funding cuts are curtailing efforts to fight the ...

Tuberculosis remains the number one cause of infectious mortality worldwide A candidate mRNA vaccine that boosts immunity ...

A recent study confirms that the 100-year-old BCG vaccine does not protect against COVID-19, challenging early assumptions ...

A Tuberculosis (TB) outbreak in Kansas City, Kansas, has people on edge, with not much public knowledge about the disease or ...

A live-attenuated tuberculosis (TB) vaccine candidate in development elicits a much more balanced and effective immune response compared to the existing vaccine used across much of the world, ...

Tuberculosis vaccine shows superior immune response protection in nonhuman primates when compared to existing BCG vaccine A ...

Taking a step further to achieve total eradication of tuberculosis, the Rajasthan government on Tuesday launched the Adult BCG vaccination campaign.

The new treatment regimen, recommended for patients aged three months to 16 years with non-severe drug-susceptible TB, is ...

With increasing mass movement, including due to climate change and war, the maxim "TB anywhere is TB everywhere" is more ...

Following the Bacillus Calmette-Guérin shortage, the first patient with bladder cancer has been dosed with recombinant ...